Frontiers in Pharmacology of Infectious Diseases has organized a series of special edition Research Topics with the goal of highlighting the achievements made by scientists and the latest advancements in research across the field of the treatment and prevention of infectious diseases; this collection aims to spotlight the research on the development of novel antiviral agents. This editorial initiative aims to focus on new insights, novel developments, current challenges, latest discoveries, recent advances, and future perspectives in the field of antiviral agents.
The Research Topic welcomes forward-looking contributions from scientists researching these pharmacological agents, outlining recent developments and major accomplishments that have been achieved and that need to occur to move the field forward in antiviral agents.
The goal of this special edition Research Topic is to shed light on the progress made in the field of antiviral agents in the treatment of infectious diseases including, but not limited to, COVID-19, measles, rubella, chickenpox, roseola, smallpox, chikungunya viral infections. This article collection hopes to inform and provide insight to researchers on the current findings in the field. Furthermore, we aim to create a collective resource of the cutting research in all aspects of the pharmacology of infectious diseases.
This Research Topic series also covers:
Spotlight On: Novel Antibacterial Agents in the treatment and prevention of Infectious DiseasesSpotlight On: Novel Antifungal Agents in the treatment and prevention of Infectious DiseasesSpotlight On: Novel Antiparasitic Agents in the treatment and prevention of Infectious DiseasesWe welcome original research, review, systematic review, perspectives and theory articles to be submitted to this collection.
Frontiers in Pharmacology of Infectious Diseases has organized a series of special edition Research Topics with the goal of highlighting the achievements made by scientists and the latest advancements in research across the field of the treatment and prevention of infectious diseases; this collection aims to spotlight the research on the development of novel antiviral agents. This editorial initiative aims to focus on new insights, novel developments, current challenges, latest discoveries, recent advances, and future perspectives in the field of antiviral agents.
The Research Topic welcomes forward-looking contributions from scientists researching these pharmacological agents, outlining recent developments and major accomplishments that have been achieved and that need to occur to move the field forward in antiviral agents.
The goal of this special edition Research Topic is to shed light on the progress made in the field of antiviral agents in the treatment of infectious diseases including, but not limited to, COVID-19, measles, rubella, chickenpox, roseola, smallpox, chikungunya viral infections. This article collection hopes to inform and provide insight to researchers on the current findings in the field. Furthermore, we aim to create a collective resource of the cutting research in all aspects of the pharmacology of infectious diseases.
This Research Topic series also covers:
Spotlight On: Novel Antibacterial Agents in the treatment and prevention of Infectious DiseasesSpotlight On: Novel Antifungal Agents in the treatment and prevention of Infectious DiseasesSpotlight On: Novel Antiparasitic Agents in the treatment and prevention of Infectious DiseasesWe welcome original research, review, systematic review, perspectives and theory articles to be submitted to this collection.